Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$92.27 - $101.54 $1.08 Million - $1.19 Million
-11,726 Reduced 32.94%
23,873 $2.41 Million
Q3 2023

Oct 13, 2023

BUY
$94.73 - $105.13 $375,130 - $416,314
3,960 Added 12.52%
35,599 $3.63 Million
Q2 2023

Jul 18, 2023

BUY
$92.52 - $104.91 $109,728 - $124,423
1,186 Added 3.89%
31,639 $3.19 Million
Q1 2023

May 04, 2023

BUY
$80.03 - $92.81 $14,645 - $16,984
183 Added 0.6%
30,453 $2.8 Million
Q4 2022

Jan 31, 2023

BUY
$75.55 - $92.52 $138,634 - $169,774
1,835 Added 6.45%
30,270 $2.75 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $864,431 - $1.01 Million
11,586 Added 68.76%
28,435 $2.16 Million
Q2 2022

Aug 23, 2022

SELL
$80.52 - $93.75 $59,262 - $69,000
-736 Reduced 4.19%
16,849 $1.42 Million
Q1 2022

Apr 29, 2022

SELL
$80.11 - $90.62 $3,524 - $3,987
-44 Reduced 0.25%
17,585 $1.54 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $4,463 - $4,935
56 Added 0.32%
17,629 $1.54 Million
Q3 2021

Nov 08, 2021

BUY
$81.78 - $95.14 $385,265 - $448,204
4,711 Added 36.63%
17,573 $1.44 Million
Q2 2021

Jan 28, 2022

SELL
$85.24 - $94.15 $55,491 - $61,291
-651 Reduced 4.82%
12,862 $1.17 Million
Q1 2021

Jan 27, 2022

BUY
$83.5 - $98.47 $111,138 - $131,063
1,331 Added 10.93%
13,513 $1.16 Million
Q4 2020

Feb 11, 2021

BUY
$78.07 - $94.43 $190,490 - $230,409
2,440 Added 25.05%
12,182 $1.15 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $63,001 - $69,797
767 Added 8.55%
9,742 $847,000
Q2 2020

Aug 11, 2020

BUY
$80.93 - $91.1 $140,170 - $157,785
1,732 Added 23.91%
8,975 $784,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $131,234 - $183,861
-1,857 Reduced 20.41%
7,243 $597,000
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $108,811 - $123,027
1,290 Added 16.52%
9,100 $862,000
Q3 2019

Nov 08, 2019

SELL
$85.54 - $94.26 $63,299 - $69,752
-740 Reduced 8.65%
7,810 $679,000
Q2 2019

Aug 16, 2019

BUY
$75.4 - $92.8 $644,670 - $793,440
8,550 New
8,550 $781,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.